The MajesTEC-9 trial showed a 40% reduced risk of death and a 71% reduced risk of disease progression or death with ...

"The Great Healthcare Plan" aims to lower drug costs, reduce premiums, and enhance price transparency, with a focus on Most ...

Volunteering among Black adolescents from lower-income families is linked to lower metabolic syndrome scores and reduced diabetes risk. Purpose in life mediates the relationship between volunteering ...

Reducing liver fat has become a central target in the development of therapies for metabolic dysfunction–associated ...

Despite HCM’s strong genetic basis, patients residing in lower-income or more socially deprived areas faced significantly ...

Project LiBRha aims to improve pediatric STS diagnosis and treatment through comprehensive molecular testing and liquid biopsy integration. The initiative involves 18 centers and partnerships with the ...

Microwave ablation plus chemotherapy significantly improves progression-free survival in advanced NSCLC without increasing toxicity compared to chemotherapy alone. The combination treatment leverages ...

Digital health platforms improve pediatric care by offering customized, interactive tools for children and parents. They enhance education, support, and engagement while tackling challenges related to ...

ICHRAs have been growing in popularity, but not without skepticism. While some consumers think they are inferior to ...

Integration of targeted therapies and immunotherapies offers new hope, enhancing survival rates and quality of life. Patients with mantle cell lymphoma experienced better survival rates when treated ...

Retrospective studies show elevated risks, especially for glomerular or proteinuric kidney disease, but absolute risk remains ...

Explore the latest HER2-targeted therapies for non-small cell lung cancer, including treatment options and patient-centered decision-making strategies.